CN1899425A - Chinese medicine composition for treating emmeniopathy - Google Patents
Chinese medicine composition for treating emmeniopathy Download PDFInfo
- Publication number
- CN1899425A CN1899425A CN 200610052243 CN200610052243A CN1899425A CN 1899425 A CN1899425 A CN 1899425A CN 200610052243 CN200610052243 CN 200610052243 CN 200610052243 A CN200610052243 A CN 200610052243A CN 1899425 A CN1899425 A CN 1899425A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- parts
- herba lysimachiae
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 208000019255 Menstrual disease Diseases 0.000 title abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 230000000694 effects Effects 0.000 claims abstract description 20
- 239000008187 granular material Substances 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 10
- 241000123069 Ocyurus chrysurus Species 0.000 claims abstract description 7
- 238000010992 reflux Methods 0.000 claims abstract description 3
- 239000000284 extract Substances 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 12
- 239000003826 tablet Substances 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000000890 drug combination Substances 0.000 claims 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims 1
- 238000005457 optimization Methods 0.000 claims 1
- 230000005906 menstruation Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 244000061520 Angelica archangelica Species 0.000 abstract 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 2
- 240000007890 Leonurus cardiaca Species 0.000 abstract 2
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 2
- 241000219991 Lythraceae Species 0.000 abstract 1
- 240000005893 Pteridium aquilinum Species 0.000 abstract 1
- 235000009936 Pteridium aquilinum Nutrition 0.000 abstract 1
- 240000005255 Rubus parvifolius Species 0.000 abstract 1
- 235000018803 Rubus parvifolius Nutrition 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002229 urogenital system Anatomy 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of Chinese medicine composition for treating emmeniopathy. The Chinese medicine composition is granule prepared with loosestrife, motherwort, angelica, Japanese raspberry root, bracken, madder and other Chinese medicine materials, and through reflux extracting angelica and motherwort with 70-95 % alcohol solution, concentrating and drying to obtain extractum I; decocting all the Chinese medicine materials including alcohol extracted residue, concentrating and drying to obtain extractum II, merging the extractum I and the extractum II; and further steps. The Chinese medicine composition possesses functions of benefiting qi, nourishing blood, promoting blood circulation to regulate menstruation, dissipating blood stasis and relieving pain; is used in treating abnormal menstruation, dysmenorrheal and other emmeniopathy, and has the advantages of high curative effect, low cost, no toxic side effect, etc.
Description
Technical field
The present invention relates to field of medicaments, is a kind of Chinese medicine composition for the treatment of menopathy specifically
Background technology
The inflammation of menoxenia, dysmenorrhea, amenorrhea, various urogenital systems such as vaginitis, pelvic inflammatory disease, endometritis, adnexitis etc. are women's frequently-occurring disease and commonly encountered diseases in life.Relatively poor, diseases such as the weak easier trouble menopathy of women such as dysmenorrhea, menoxenia, amenorrhea, lochia after being ill of body constitution particularly.The menoxenia sickness rate is higher, often occupies first of the gynaecopathia.At present, doctor trained in Western medicine does not also have good treatment means to these diseases, this type of gynaecopathia of western medicine, and not only weak curative effect, easily recurrence, and also side effect is big.Particularly in order to the medicine of treatment women's diseases such as dysmenorrhea, amenorrhea, leukorrhagia, the very little or basic inefficacy of its curative effect has only by taking good care of slowly, and this brings very big inconvenience and misery to the women.
Summary of the invention
Purpose of the present invention overcomes exactly that the Western medicine side effect is big, curative effect not significantly or reason such as form of Chinese drug, the deficiency of technology such as curative effect instability, according to traditional Chinese medical science prescription and preparation principle to Chinese medicine composition advantages such as meticulously development provides a kind of pointed strong, good effect, the cycle is short, price is low, have no side effect, the patient is taken like a shot, can treat the pure Chinese medicinal preparation of menopathy preferably.It all has good effect to inflammation of menoxenia, dysmenorrhea, amenorrhea, various urogenital systems etc.This meets numerous doctors and patient's common aspiration fully.
The present invention develops Chinese medicine composition meticulously according to traditional Chinese medical science prescription and preparation principle, realizes by following technical scheme:
The consumption of drug component of the present invention is groped to sum up to draw through the inventor in a large number, and each amounts of components all has curative effect preferably in following ranges, and medicine of the present invention contains
166～498 parts of 166～498 parts of Radix Angelicae Sinensis of 331～999 parts of Herba Leonuris of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis)
166～498 parts in 166～498 portions of Radix Rubiaes of 166～498 portions of Herba Pteridis Multifidaes of radix rubi parvifol
Preferable range is:
248～496 parts of 248～496 parts of Radix Angelicae Sinensis of 498～998 parts of Herba Leonuris of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis)
248～496 parts in 248～496 portions of Radix Rubiaes of 248～496 portions of Herba Pteridis Multifidaes of radix rubi parvifol
Optimum weight part is:
331 parts of 331 parts of Radix Angelicae Sinensis of 662 parts of Herba Leonuris of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis)
331 parts in 222 portions of Radix Rubiaes of 331 portions of Herba Pteridis Multifidaes of radix rubi parvifol
Technical problem to be solved by this invention is to realize by following technical scheme.Be characterized in that with Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), Herba Leonuri, Radix Angelicae Sinensis, radix rubi parvifol, Herba Pteridis Multifidae, Radix Rubiae etc. be the medicine that raw material is made.The Chinese medicine composition of this treatment menopathy is characterized in that it is that component is formed or made active component and pharmaceutically acceptable additives are formed or make active component and pharmaceutically acceptable additives are formed by the alcohol extract of following main materials by the water extract of following main materials by following main materials.The present invention is by scientific combination, development meticulously, effect with benefiting QI and nourishing blood, promoting blood flow to regulate menstruation, eliminating stasis to stop pain, have advantages such as good effect, the cycle is short, price is low, have no side effect, it all has good curative effect to various menstruation diseases such as gynecological's menoxenia, dysmenorrhea, amenorrheas.
Medicine of the present invention can adopt the Chinese medicine preparation conventional method to be prepared into any pharmaceutically useful conventional formulation.For example these crude drug pulverize mix homogeneously can be made powder takes after mixing it with water; Also can be with these medicines decocting together, the condensed water decocting liquid is made oral liquid then; But, preferably crude drug Radix Angelicae Sinensis, Herba Leonuri are carried out ethanol extraction, but this can not limit protection scope of the present invention in order to make each crude drug of this medicine better bring into play drug effect.
Described pharmaceutically acceptable additives are following one or more: glycerol, gelatin, Polyethylene Glycol, propylene glycol, dextrin, ethanol, dried starch, citric acid, sodium bicarbonate, ethyl hydroxybenzoate, tartaric acid, lecithin, sodium lauryl sulphate.
Its dosage form can be a said dosage form on any pharmaceutics, as syrup, granule, capsule, tablet etc.; Described capsule can be common capsule, effervescent capsule or other various suitable capsules; Described tablet can be common tablet, effervescent tablet, dispersible tablet or other various suitable tablets, can be with suitable coating material coating also coating not; The preferred particulates agent.
The specific embodiment
Describe implementation of the present invention in detail below in conjunction with embodiment.
Embodiment 1:
The preparation method of granule of the present invention: medicine of the present invention can prepare by the following method:
(a) take by weighing former medicines such as Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 500 grams, Herba Leonuri 500 grams, Radix Angelicae Sinensis 500 grams, radix rubi parvifol 250 grams, Herba Pteridis Multifidae 350, Radix Rubiae 250 grams and that coarser powder is ground in its pulverizing is standby by weight ratio;
(b) Radix Angelicae Sinensis, the Herba Leonuri with described weight proportion carries out reflux, extract, twice with 70%～95% ethanol, merges extracted twice liquid, reclaims ethanol, is condensed into proportion and is 1.15～1.35 extractum, 45～55 ℃ dry down, dry extract 1;
(c) Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), radix rubi parvifol, Herba Pteridis Multifidae, Radix Rubiae and the Radix Angelicae Sinensis of described weight proportion, the residue after the Herba Leonuri alcohol extraction are decocted with water twice, add water serves as easy not have powder at every turn, merge decocting liquid twice, filter to get filtrate 2, it is 1.15～1.35 extractum that concentrated filtrate becomes proportion, dry under 45～55 ℃, get dry extract 2;
(d) merge dry extract 1 and 2, it is ground into powder, the active component of preparation cost invention medicine;
(e) with gained active component and pharmaceutically acceptable additives such as correctives, the abundant mixing of adjuvant, make any dosage form of pharmaceutics.As above-mentioned active component was pulverized 100 mesh sieves, with pharmaceutically acceptable additives such as mixings such as ethanol, starch, moistening, soften, take out when forming agglomerate, make dissolved granule.
In the above-mentioned preparation method, when in the preferred steps (b) medicine being added ethanol extraction, adding amount of alcohol for the first time is 12 times, extracts 1 hour, and add amount of alcohol the second time is 10 times, extracts 1 hour.(c) during with the medicine extracting in water, add 10 times in water for the first time in, decocted 2 hours, add 8 times in water the second time, decocted 1.5 hours.
Embodiment 2:
The preparation method of syrup of the present invention:, each 1 hour, filter with Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 600 grams, Herba Leonuri 500 grams, Radix Angelicae Sinensis 450 grams, radix rubi parvifol 250 grams, Herba Pteridis Multifidae 250, Radix Rubiae 350 gram decocting secondaries, merging filtrate, be condensed into thick paste, add the ethanol precipitation secondary, make to contain pure flow control and once reach 65%, for the second time reach 80%, filter, reclaim ethanol and be concentrated into about 700mL, stir molten with sucrose, ethyl hydroxybenzoate alcohol liquid while hot, add boiling water again to full dose, stir evenly promptly to get and make syrup.
Embodiment 3:
The preparation method of tablet of the present invention:
The broken coarser powder that grind into of former medicated powder such as Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 500 grams, Herba Leonuri 400 grams, Radix Angelicae Sinensis 450 grams, radix rubi parvifol 250 grams, Herba Pteridis Multifidae 250 grams, Radix Rubiae 350 grams is standby; After making granule by example 1 method, add an amount of additives, mixing, tabletting, coating are made suitable tablet.
In like manner, press the method for embodiment 1, add suitable capsule etc.
Preparation of the present invention is fragrant faint yellow granule, sepia syrup or tablet or capsule.
More than during each forms, weight is calculated with crude drug, in the present invention, if weight is unit with the gram, this composition can be made into 1000 doses of pharmaceutical preparatioies, described 1000 doses of fingers, 1000 doses in the final drug preparation of making, as make 1000 in 1000 of capsule preparations, 1000 in tablet, granule 1000g, oral liquid 1000 peace bottles, injection 1000 peace bottles, drop pill etc., also can make big packing as granule, as the 100-500 bag, specifically can be 100 bags, 150 bags, 200 bags, 250 bags, 500 bags, every bag can be used as dose 1 time.This weight of formulation can increase or reduce, but the raw medicinal herbs weight proportion constant rate between each composition.
For a better understanding of the present invention, below further set forth the action effect of medicine of the present invention in pharmacology and clinical research, but not to the restriction of effect of the present invention.
Observe 128 routine patients, be divided into 2 groups.Matched group 60 examples adopt the treatment of control drug YANGXUE DANGGUI JING, and treatment group 68 examples adopt the treatment of this medicine, and clinical effectiveness is as follows:
| Clinical | The basic healing | Effectively | Invalid | Total effective rate (%) |
| Treatment group matched group | 52 36 | 12 10 | 4 14 | 94.12 76.67 |
According to above clinical effectiveness, the present invention is by scientific combination, development meticulously, really the effect that has benefiting QI and nourishing blood, promoting blood flow to regulate menstruation, eliminating stasis to stop pain, have advantages such as good effect, the cycle is short, price is low, have no side effect, it all has good curative effect to various menstruation diseases such as gynecological's menoxenia, dysmenorrhea, amenorrheas.
Claims (8)
1, a kind of Chinese medicine composition for the treatment of menopathy is characterized in that it is that component is formed or made active component and pharmaceutically acceptable additives are formed or make active component and pharmaceutically acceptable additives are formed by the alcohol extract of following main materials by the water extract of following main materials by following main materials: the consumption of drug component of the present invention is groped to sum up to draw through the inventor in a large number, each amounts of components all has curative effect preferably in following ranges, and medicine of the present invention contains
166～498 parts of 166～498 parts of Radix Angelicae Sinensis of 331～999 parts of Herba Leonuris of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis)
166～498 parts in 166～498 portions of Radix Rubiaes of 166～498 portions of Herba Pteridis Multifidaes of radix rubi parvifol
2, pharmaceutical composition according to claim 1 is characterized in that formula optimization is:
Preferable range is:
248～496 parts of 248～496 parts of Radix Angelicae Sinensis of 498～998 parts of Herba Leonuris of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis)
248～496 parts in 248～496 portions of Radix Rubiaes of 248～496 portions of Herba Pteridis Multifidaes of radix rubi parvifol
3, pharmaceutical composition according to claim 1, optimum weight part is:
331 parts of 331 parts of Radix Angelicae Sinensis of 662 parts of Herba Leonuris of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis)
331 parts in 222 portions of Radix Rubiaes of 331 portions of Herba Pteridis Multifidaes of radix rubi parvifol
4, pharmaceutical composition according to claim 1 is characterized in that: described pharmaceutically acceptable additives are following one or more: glycerol, gelatin, Polyethylene Glycol, propylene glycol, dextrin, dried starch, ethylparaben, tartaric acid, citric acid, sodium bicarbonate, lecithin, sodium lauryl sulphate.
5, preparation of drug combination method as claimed in claim 1 is characterized in that comprising the steps:
(a) take by weighing former medicines such as Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), radix rubi parvifol, Herba Pteridis Multifidae, Radix Rubiae and Radix Angelicae Sinensis, Herba Leonuri and that coarser powder is ground in its pulverizing is standby by the optimum weight proportioning;
(b) Radix Angelicae Sinensis, the Herba Leonuri with described weight proportion carries out reflux, extract, twice with 70%～95% ethanol, merges extracted twice liquid, reclaims ethanol, is condensed into proportion and is 1.15～1.35 extractum, 45～55 ℃ dry down, dry extract 1;
(c) Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), radix rubi parvifol, Herba Pteridis Multifidae, Radix Rubiae and the Radix Angelicae Sinensis of described weight proportion, the residue after the Herba Leonuri alcohol extraction are decocted with water twice, add water serves as easy not have powder at every turn, merge decocting liquid twice, filter to get filtrate 2, it is 1.15～1.35 extractum that concentrated filtrate becomes proportion, dry under 45～55 ℃, get dry extract 2;
(d) merge dry extract 1 and 2, it is ground into powder, the active component of preparation cost invention medicine;
(e) with gained active component and pharmaceutically acceptable additives such as correctives, the abundant mixing of adjuvant, make any dosage form of pharmaceutics.As above-mentioned active component was pulverized 100 mesh sieves, with pharmaceutically acceptable additives such as mixings such as ethanol, starch, moistening, soften, take out when forming agglomerate, make dissolved granule.
6, by in the above-mentioned preparation method of claim 5, when in the preferred steps (b) medicine being added ethanol extraction, adding amount of alcohol for the first time is 12 times, extracts 1 hour, and add amount of alcohol the second time is 10 times, extracts 1 hour.Spissated extractum proportion is 1.15.
7, by in the above-mentioned preparation method of claim 5, during with the medicine extracting in water, add 10 times in water for the first time in the preferred steps (c), decocted 2 hours, add 8 times in water the second time, decocted 1.5 hours.Spissated extractum proportion is 1.20.
8, pharmaceutical composition according to claim 1 is characterized in that: its dosage form can be a said dosage form on any pharmaceutics, as effervescent granule electuary, capsule, tablet etc.; Described capsule can be common capsule, effervescent capsule or other various suitable capsules; Described tablet can be common tablet, effervescent tablet, dispersible tablet or other various suitable tablets, can be with suitable coating material coating also coating not; The preferred particulates agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006100522435A CN1899425B (en) | 2006-06-30 | 2006-06-30 | Chinese medicine composition for treating emmeniopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006100522435A CN1899425B (en) | 2006-06-30 | 2006-06-30 | Chinese medicine composition for treating emmeniopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1899425A true CN1899425A (en) | 2007-01-24 |
| CN1899425B CN1899425B (en) | 2011-12-07 |
Family
ID=37655536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006100522435A Expired - Fee Related CN1899425B (en) | 2006-06-30 | 2006-06-30 | Chinese medicine composition for treating emmeniopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1899425B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103006876A (en) * | 2013-01-09 | 2013-04-03 | 张守红 | Externally used traditional Chinese medicine pills for treating metrorrhagia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1135905A (en) * | 1995-05-18 | 1996-11-20 | 辽宁中医学院附属医院 | Medicine for regulating menstruation |
| CN1456245A (en) * | 2003-02-18 | 2003-11-19 | 毛友昌 | Preparation of tablets for profuse menstruation |
-
2006
- 2006-06-30 CN CN2006100522435A patent/CN1899425B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103006876A (en) * | 2013-01-09 | 2013-04-03 | 张守红 | Externally used traditional Chinese medicine pills for treating metrorrhagia |
| CN103006876B (en) * | 2013-01-09 | 2013-10-30 | 张守红 | Externally used traditional Chinese medicine pills for treating metrorrhagia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1899425B (en) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1739611A (en) | Stasis relieving oral liquid for treating rhinitis and its prepn | |
| CN1966052A (en) | Tablet containing red sage root and astragalus root for removing blood stasis and preparation process thereof | |
| CN1935194B (en) | Preparation method of Chinese medicine composition for treating nephroma | |
| CN1814195B (en) | Chinese medicine composition for treating gynecopathy and its preparation method thereof | |
| CN101474192A (en) | Veramyst medicinal preparation and preparation method | |
| CN108543044B (en) | Combined medicine for treating acne and application thereof | |
| CN1814176B (en) | Chinese medicinal composition for treating tuberculosis and its preparation method | |
| CN1899425B (en) | Chinese medicine composition for treating emmeniopathy | |
| CN1899574A (en) | Chinese medicine composition for preventing and controlling liver cancer and its use | |
| CN101658585A (en) | Application of Chinese medicinal composition in preparing medicament for treating nasosinusitis | |
| CN1259078C (en) | Chinese medicine for treating women's chronic pelvic infection | |
| CN1814250B (en) | Chinese medicine composition for treating liver cirrhosis ascites and preparation method thereof | |
| CN1830482B (en) | Chinese medicinal composition and application for treating child pneumonia for treating | |
| CN101700323B (en) | Pharmaceutical composition for preventing and treating liver cancer | |
| CN1943661A (en) | A Chinese traditional medicinal composition and its preparation method | |
| CN101194959B (en) | Capsule for treating headache and method for preparing the same | |
| CN1814193B (en) | Chinese medicine composition for treating nephritis dropsy and preparation method thereof | |
| CN1814217A (en) | Chinese medicine composition for treating rheumatoid arthritis and use thereof | |
| CN1814194A (en) | Chinese-western medicine composition for treating in fant's common cold and use thereof | |
| CN1166352A (en) | Wind dispelling and itching stopping medicine and its production | |
| CN1915401B (en) | Composition of Chinese traditional medicine for treating phthisis, and application | |
| CN115554345B (en) | A Chinese medicinal compound preparation for treating gout and hyperuricemia, and its preparation method | |
| CN1899416A (en) | Chinese medicine composition for treating rheumatism and its use | |
| CN1977904A (en) | Chinese medicine composition for treating gynecologic inflammation suchas pelvic inflammation, adnexal inflammation | |
| CN1456245A (en) | Preparation of tablets for profuse menstruation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20090109 Address after: Zhejiang city of Ningbo province Yinzhou District Yinxian Avenue East Zhejiang Pharmaceutical College No. 888 post encoding: 315100 Applicant after: Yang Xiong Zhi Co-applicant after: Yang Yijie Address before: 21, 4 floor, 293 South Rainbow Road, Jiangdong District, Zhejiang, Ningbo, China: 315040 Applicant before: Yang Yijie |
|
| ASS | Succession or assignment of patent right |
Owner name: YANG XIONGZHI Free format text: FORMER OWNER: YANG YIKAI Effective date: 20090109 |
|
| ASS | Succession or assignment of patent right |
Owner name: NINGBO YUANZHI BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: YANG XIONGZHI Effective date: 20110927 Free format text: FORMER OWNER: YANG YIKAI |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20110927 Address after: 315100, room 10, building 68, Lane 402, Tai Mo Road, Ningbo, Zhejiang, Yinzhou District Applicant after: Ningbo Yuanzhi Biotechnology Co., Ltd. Address before: 315100 Zhejiang city of Ningbo province Yinzhou District County Road No. 888 east section of Zhejiang Pharmaceutical College Applicant before: Yang Xiongzhi Co-applicant before: Yang Yijie |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111207 Termination date: 20140630 |
|
| EXPY | Termination of patent right or utility model |